Offer - Urjas Oil for just ₹ 1 X
Irbotan-150 is an allopathic medicine The correct dosage of Irbotan-150 depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Irbotan-150 is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Irbotan-150 safe for pregnant women?
Irbotan-150 has many dangerous side effects in pregnant women. If you are pregnant, do not consume Irbotan-150 without medical advice.
Is the use of Irbotan-150 safe during breastfeeding?
Irbotan-150 has been seen to have minimal side effects on breastfeeding women.
What is the effect of Irbotan-150 on the Kidneys?
There are no side effects of Irbotan-150 on the kidneys.
What is the effect of Irbotan-150 on the Liver?
Irbotan-150 does not damage the liver.
What is the effect of Irbotan-150 on the Heart?
Side effects of Irbotan-150 rarely affect the heart.
Irbotan-150 should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Irbotan-150 unless your doctor advises you to do so -
Is this Irbotan-150 habit forming or addictive?
No, you will not get addicted to Irbotan-150.
Interaction between Food and Irbotan-150
Irbotan-150 may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Irbotan-150
Information about the interaction of Irbotan-150 and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Avapro®* (irbesartan)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 506,507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173